TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Invest your way with confidence.

  • ✓Powerful tools & research — at no extra cost
  • ✓Stocks, ETFs, options & more
  • ✓Competitive fees + USD accounts
Stocks/TSX/GILD

Gilead Sciences CDR (CAD Hedged) (GILD : TSX)

Common Stock

$30.43

CAD

+0.84 (2.84%)

Last updated: 2026-10-09

💰

Dividend Declared

29 days ago

$0.1649 CAD per share dividend. Ex-dividend date: September 15, 2026 • Payment date: October 7, 2026

Follow GILD

GILD

Gilead Sciences CDR (CAD Hedged)

Source:WealthAwesomeWealthAwesome
↑ $1.07 (3.64%)
30 day period
$28.97$29.91$30.84Aug 28Sep 21Oct 9

Performance

1 Day

+0.00%

1 Week

+4.50%

1 Month

+5.00%

YTD

+22.11%

Key Statistics

Market Cap

$174.33B

52W High

$31.24

52W Low

$23.05

P/E Ratio

-

50 Day MA

$29.12

200 Day MA

$27.99

Beta

-

Dividend Yield

10.88%

Advertisement

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/9/2026$30.17$30.44$30.17$30.43$30.433,000
10/8/2026$29.21$29.69$29.21$29.59$29.595,604
10/7/2026$29.74$29.74$29.51$29.51$29.51606
10/6/2026$29.25$29.25$28.94$28.97$28.971,137
10/5/2026$29.11$29.12$29.00$29.12$29.121,171
10/2/2026$29.95$29.95$29.07$29.19$29.194,049
10/1/2026$29.83$29.83$29.67$29.67$29.6714,163
9/30/2026$30.18$30.18$30.06$30.06$30.06379
9/29/2026$30.61$30.61$30.00$30.54$30.541,489
9/28/2026$30.19$30.70$30.19$30.66$30.664,501

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GILD's historical volatility

HistoricalForecast68%95%
C$23.95C$28.86C$33.76C$38.67C$43.58C$48.49TodayJun 1Aug 7Oct 9Nov 21Jan 4Feb 16

30-Day Vol

21.6%

Annualized

90-Day Vol

28.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$36.38

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$32.30C$29.98 – C$34.79
60 trading daysC$34.28C$30.85 – C$38.08
90 trading daysC$36.38C$31.98 – C$41.38

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Gilead Sciences CDR (CAD Hedged)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
4049.30%
EPS (Diluted)
0.00
Book Value
-

Recent Dividends

$0.000$0.084$0.1672025-06-13: $0.16402025-09-15: $0.16332025-12-15: $0.16012026-03-13: $0.16702026-09-15: $0.1649Jun 25Dec 25Sep 26

$0.1649CAD

Ex: Sep 15, 2026

Pay: Oct 7

Quarterly

$0.1670CAD

Ex: Mar 13, 2026

$0.1601CAD

Ex: Dec 15, 2025

$0.1633CAD

Ex: Sep 15, 2025

$0.1640CAD

Ex: Jun 13, 2025

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About GILD

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
AABAberdeen International Inc.$0.02+0.00%
ACDAccord Financial Corp.$0.75+0.00%
AIIAlmonty Industries Inc$15.51+0.00%
AKT-AAKITA Drilling Ltd$3.41+0.00%
APSAptose Biosciences Inc$2.40+0.00%
ASCUArizona Sonoran Copper Company Inc$8.06+0.00%
ATCUAlta Copper Corp.$1.39+0.00%
AX-UNArtis Real Estate Investment Trust$25.61+0.00%

GILD.TO news timeline

2 articles covering GILD.TO, most recent first

Latest

Gilead Sciences CDR (CAD Hedged) (GILD.TO) pays CA$0.1649 today

•Investing

Advertisement